Journal of Clinical Trials
Open Access
ISSN: 2167-0870
ISSN: 2167-0870
Department of Ophthalmology, MelmaruvathurAdhiparasakthi Institute of Medical Sciences and Research, Kancheepuram, Tamil Nadu, India
Hemmanth Raj M is currently working in Department of Ophthalmology, MelmaruvathurAdhiparasakthi Institute of Medical Sciences and Research, Kancheepuram, Tamil Nadu, India. He has published numerous research papers and articles in reputed journals and has various other achievements in the related studies. He has extended his valuable service towards the scientific community with his extensive research work.
Review Article
Convalescent Plasma as a Plausible Therapeutic Option for nCOVID-19: A Review
Author(s): Talagavadi Channaiah Anudeep, Madhan Jeyaraman*, Dharma U Shetty, Hemmanth Raj M, Ajay SS, Rajeswari Somasundaram, Vinodh Kumar V, Rashmi Jain and ShirodkarJaswandi Dilip
The world is battling a pandemic caused by the newly emerged strain of coronavirus; upon identification SARSCoV-2 and in interim named nCOVID-19 by the World Health Organization (WHO). The contagion has sparked a war against humanity with the current global toll of 1,12,241 human lives. Till date no definitive treatment against SARS-CoV-2 has been established. Similar picture of lack of licensed definitive therapy can be traced back to Ebola outbreak and the WHO directed for considering convalescent plasma (CP) therapy for its control. The history of CP as therapeutics dates back to 20th century which renders a scope for consideration in the management of nCOVID-19. Experience from prior outbreak of SARS-CoV-1 has shown that convalescent sera contain neutralizing antibodies to the relevant virus. The core principle of this passive antibody therapy is based on retrieving virus neutrali.. View More»
DOI:
10.35248/2167-0870.20.10.409